MS
Michelle Schoettler
Emory University
Research areas: Medicine · Hematology · Hematopoietic Stem Cell Transplantation · Complement system in diseases · Renal Transplantation Outcomes and Treatments
0000-0003-4565-6399
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Cystatin C Based eGFR Identifies Clinically Significant Acute Kidney Injury Missed by Serum Creatinine in Pediatric Transplant-Associated Thrombotic Microangiopathy Save
- Sirolimus Dose Reduction After Belumosudil Initiation in Pediatric and Young Adult Patients With Chronic Graft‐Versus‐Host‐Disease Save
- How Clinicians Manage Sleep During Inpatient Hospitalization Following Pediatric Hematopoietic Stem Cell Transplantation Save
- Eculizumab for Pediatric Hematopoietic Cell Transplant–Associated Thrombotic Microangiopathy: Real-World Response Rates, Predictors of Poor Response, and an Optimal Time Point for Treatment Response Assessment Save
- Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive care Save
- Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA‐TMA) Save
- Eculizumab is Associated With Increased Infection Rates and Infection Related Mortality in Children With Thrombotic Microangiopathy After HCT Save
- An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy Save
- Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency Save
- Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children Save
- Application of the Consensus Definition of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Requires a More Expansive Lens to Accurately Diagnose and Risk Stratify Patients—Beware Reliance on Schistocytes Alone Save
- Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis Save
- Pediatric transplant–associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy Save
- Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children Save
- D‐dimer and sinusoidal obstructive syndrome‐novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study Save
- Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis Save
- Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children Save
- Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort Save
- Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation Save
- Severe, persistent neurotoxicity after transplant‐associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab Save